Stroke Prevention Versus Bleeding Risk in Atrial Fibrillation: A Clinical Dilemma
- 11 January 2011
- journal article
- editorial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 57 (2) , 181-183
- https://doi.org/10.1016/j.jacc.2010.09.026
Abstract
No abstract availableKeywords
Funding Information
- St. Jude Medical
- Sanofi
This publication has 26 references indexed in Scilit:
- Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial FibrillationJournal of the American College of Cardiology, 2011
- Persistent Use of Secondary Preventive Drugs Declines Rapidly During the First 2 Years After StrokeStroke, 2010
- Potentially Preventable Strokes in High-Risk Patients With Atrial Fibrillation Who Are Not Adequately AnticoagulatedStroke, 2009
- Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial FibrillationCirculation, 2007
- ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive SummaryJournal of the American College of Cardiology, 2006
- Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)American Heart Journal, 2006
- Patterns and Predictors of Warfarin Use in Patients With New-Onset Atrial Fibrillation from the FRACTAL RegistryThe American Journal of Cardiology, 2006
- Atrial fibrillation management: a prospective survey in ESC Member CountriesEuropean Heart Journal, 2005
- Combined Anticoagulant–Antiplatelet Use and Major Bleeding Events in Elderly Atrial Fibrillation PatientsStroke, 2004
- Stroke Severity in Atrial FibrillationStroke, 1996